<bill session="109" type="h" number="1446" updated="2022-02-03T05:25:26Z">
  <state datetime="2005-03-17">REFERRED</state>
  <status>
    <introduced datetime="2005-03-17"/>
  </status>
  <introduced datetime="2005-03-17"/>
  <titles>
    <title type="short" as="introduced">Methamphetamine Abuse Prevention Act of 2005</title>
    <title type="display">Methamphetamine Abuse Prevention Act of 2005</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to eliminate the safe-harbor exception for certain packaged pseudoephedrine products used in the manufacture of methamphetamine, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S001143"/>
  <cosponsors>
    <cosponsor bioguide_id="B001229" joined="2005-09-08"/>
    <cosponsor bioguide_id="B000586" joined="2005-03-17"/>
    <cosponsor bioguide_id="B001236" joined="2005-04-13"/>
    <cosponsor bioguide_id="B001245" joined="2005-03-17"/>
    <cosponsor bioguide_id="B001247" joined="2005-04-13"/>
    <cosponsor bioguide_id="B001149" joined="2005-03-17"/>
    <cosponsor bioguide_id="C001055" joined="2005-03-17"/>
    <cosponsor bioguide_id="C001053" joined="2005-04-13"/>
    <cosponsor bioguide_id="K000358" joined="2005-03-17"/>
    <cosponsor bioguide_id="M001156" joined="2005-04-13"/>
    <cosponsor bioguide_id="O000165" joined="2005-04-13"/>
    <cosponsor bioguide_id="P000263" joined="2005-03-17"/>
    <cosponsor bioguide_id="T000459" joined="2005-04-13"/>
    <cosponsor bioguide_id="W000119" joined="2005-06-23"/>
  </cosponsors>
  <actions>
    <action datetime="2005-03-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-03-17" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-03-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-03-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2005-05-10">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative remedies"/>
    <term name="Attorneys general"/>
    <term name="Authorization"/>
    <term name="Business records"/>
    <term name="Chemicals"/>
    <term name="Child health"/>
    <term name="Child welfare"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Computer software"/>
    <term name="Computers"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Criminal investigation"/>
    <term name="Department of Health and Human Services"/>
    <term name="Department of Justice"/>
    <term name="Drug abuse"/>
    <term name="Drug abuse treatment"/>
    <term name="Drug industry"/>
    <term name="Drug law enforcement"/>
    <term name="Drug traffic"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Electronic data interchange"/>
    <term name="Environmental Protection"/>
    <term name="Equipment and supplies"/>
    <term name="Export controls"/>
    <term name="Exports"/>
    <term name="Families"/>
    <term name="Federal aid to Indians"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal aid to law enforcement"/>
    <term name="Federal aid to research"/>
    <term name="Federal-state relations"/>
    <term name="Fines (Penalties)"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Grants-in-aid"/>
    <term name="Hazardous wastes"/>
    <term name="Health"/>
    <term name="Housing and Community Development"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Interstate relations"/>
    <term name="Labor and Employment"/>
    <term name="Law"/>
    <term name="Law enforcement officers"/>
    <term name="Legal education"/>
    <term name="Medical research"/>
    <term name="Methamphetamine"/>
    <term name="Minorities"/>
    <term name="Native Americans"/>
    <term name="Nonprofit organizations"/>
    <term name="Packaging"/>
    <term name="Police training"/>
    <term name="Prosecution"/>
    <term name="Public prosecutors"/>
    <term name="Recidivists"/>
    <term name="Recruiting of employees"/>
    <term name="Research centers"/>
    <term name="Research grants"/>
    <term name="Retail trade"/>
    <term name="Rural crime"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
    <term name="Youth services"/>
  </subjects>
  <amendments/>
  <summary date="2005-05-12T20:34:08Z" status="Introduced in House">Methamphetamine Abuse Prevention Act of 2005 - Amends the Controlled Substances Act to: (1) reduce the retail sales threshold for the sale of products containing pseudoephedrine or phenylpropanolamine from nine grams to six grams; (2) eliminate the "regulated transaction" exemption for any over-the-counter sale of such products (including blister packs) by retail distributors; (3) grant authority to establish production quotas for pseudoephedrine or phenylpropanolamine; and (4) penalize violators of such quotas.

Amends the Controlled Substances Import and Export Act to restrict the importation of ephedrine, pseudoephedrine, or phenylpropanolamine, with an exception.

Requires the Director of the Office of National Drug Control Policy to report to Congress regarding the regulation of list I chemicals, including whether some or all of such chemicals should be included in schedule V for controlled substances.

Authorizes appropriations for training to State and local prosecutors and law enforcement agents for the investigation and prosecution of methamphetamine offenses. Permits the hiring of personnel and the purchase of equipment to assist in enforcement and prosecution and in the cleanup of methamphetamine-affected areas.

Directs the Attorney General to allocate appropriated funds for the hiring and training of special assistant United States attorneys.

Amends the Public Health Service Act to provide grants for: (1) the development of drug endangered children rapid response teams to intervene on behalf of children exposed to methamphetamine; (2) methamphetamine abuse treatment, with priority for rural areas; and (3) a methamphetamine research, training, and technical assistance center.

Authorizes the Attorney General, acting through the Bureau of Justice Assistance, to award grants to States to establish methamphetamine precursor monitoring programs.</summary>
</bill>
